What clinical data is available to support the use of ev3’s products?
We support many of our new product initiatives with clinical studies in order to obtain regulatory approval and new indications and provide demonstrated medical evidence and best practices on our technologies. In 2009, our clinical studies are designed to provide both regulatory clearance and clinical indication, as well as provide novel clinical data which will be beneficial for improved peripheral and neurovascular patient treatment worldwide. For an overview of the clinical trials that ev3 is currently conducting, please refer to information contained in our latest Form 10-K and Form 10-Q.
